INDICATIONS FOR IMPLANTATION OF A PERMANENT DRIVER’S TRANSPLANTED HEART RHYTHM AND CHOICE OF A TREATMENT ELEKTROKARDIOSTIMULYATION

by S. J. Shemakin, M. G. Lukava, A. J. Kormer
Published 2009-05-01

FEATURES OF CLINICAL DISPLAYS OF THE TRANSPLANTED HEART ACUTE REJECTION

by S. J. Shemakin, A. J. Kormer, T. A. Khalilulin, V. V. Chestuhin, I. M. Iljinsky, A. G. Kuprijanova
Published 2010-06-01

CLINICAL SIGNIFICATION OF MARKER OF NEOANGIOGENESIS PLACENTA GROWTH FACTOR PLGF IN HEART TRANSPLANT RECIPIENTS

by О. P. Shevchenko, O. V. Orlova, S. El-Boustani, E. N. Kаzakov, A. J. Kormer
Published 2009-05-01

METABOLIC AND AUTOIMMUNE RISK FACTORS FOR CORONARY ARTERY DISEASE (CAD) IN HEART TRANSPLANT RECIPIENTS

by T. A. Khalilulin, O. V. Orlova, B. L. Mironkov, V. V. Chestuhin, E. N. Kazakov, A. J. Kormer, О. P. Shevchenko
Published 2010-06-01

COMPARATIVE ANALYSIS OF SOLUBLE OF CD40 LIGAND LEVELS IN HEART RECIPIENTS TREATED WITH CYCLOSPORINE A AND TACROLIMUS

by O. P. Shevchenko, T. A. Khalilulin, O. V. Orlova, E. N. Kazakov, A. J. Kormer, V. V. Сhestukhin, B. L. Mironkov
Published 2012-05-01

PREDICTIVE SIGNIFICANCE OF ANTI-HLA AUTOANTIBODIES IN HEART TRANSPLANT RECIPIENTS

by O. P. Shevchenko, T. A. Khalilulin, G. A. Olefirenko, R. M. Kurabekova, N. V. Apanasenko, A. O. Shevchenko, B. L. Mironkov, I. M. Ilyinsky, A. G. Kupriyanova, A. J. Kormer
Published 2014-05-01

EFFECT OF CYTOMEGALOVIRUS INFECTION ON THE PREDICTIVE VALUE OF CD-40 LIGAND IN HEART TRANSPLANT RECIPIENTS

by O. P. Shevchenko, T. A. Khalilulin, O. V. Orlova, E. N. Kazakov, A. J. Kormer, G. A. Oliferenko, V. V. Chestukhin, B. L. Mironkov, I. M. Ilyinsky, A. G. Kupriyanovа
Published 2012-09-01